Macular Degeneration Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1370225 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Macular Degeneration Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Macular Degeneration Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Macular Degeneration Treatment Overall Market Size
    2.1 Global Macular Degeneration Treatment Market Size: 2021 VS 2028
    2.2 Global Macular Degeneration Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Macular Degeneration Treatment Players in Global Market
    3.2 Top Global Macular Degeneration Treatment Companies Ranked by Revenue
    3.3 Global Macular Degeneration Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Macular Degeneration Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Macular Degeneration Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Macular Degeneration Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Macular Degeneration Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Macular Degeneration Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Macular Degeneration Treatment Market Size Markets, 2021 & 2028
        4.1.2 Lucentis
        4.1.3 Eylea
        4.1.4 Avastin
        4.1.5 Others
    4.2 By Type - Global Macular Degeneration Treatment Revenue & Forecasts
        4.2.1 By Type - Global Macular Degeneration Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Macular Degeneration Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Macular Degeneration Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Macular Degeneration Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Eye Clinics
        5.1.4 Others
    5.2 By Application - Global Macular Degeneration Treatment Revenue & Forecasts
        5.2.1 By Application - Global Macular Degeneration Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Macular Degeneration Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Macular Degeneration Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Macular Degeneration Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Macular Degeneration Treatment Revenue & Forecasts
        6.2.1 By Region - Global Macular Degeneration Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Macular Degeneration Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Macular Degeneration Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Macular Degeneration Treatment Revenue, 2017-2028
        6.3.2 US Macular Degeneration Treatment Market Size, 2017-2028
        6.3.3 Canada Macular Degeneration Treatment Market Size, 2017-2028
        6.3.4 Mexico Macular Degeneration Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Macular Degeneration Treatment Revenue, 2017-2028
        6.4.2 Germany Macular Degeneration Treatment Market Size, 2017-2028
        6.4.3 France Macular Degeneration Treatment Market Size, 2017-2028
        6.4.4 U.K. Macular Degeneration Treatment Market Size, 2017-2028
        6.4.5 Italy Macular Degeneration Treatment Market Size, 2017-2028
        6.4.6 Russia Macular Degeneration Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Macular Degeneration Treatment Market Size, 2017-2028
        6.4.8 Benelux Macular Degeneration Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Macular Degeneration Treatment Revenue, 2017-2028
        6.5.2 China Macular Degeneration Treatment Market Size, 2017-2028
        6.5.3 Japan Macular Degeneration Treatment Market Size, 2017-2028
        6.5.4 South Korea Macular Degeneration Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Macular Degeneration Treatment Market Size, 2017-2028
        6.5.6 India Macular Degeneration Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Macular Degeneration Treatment Revenue, 2017-2028
        6.6.2 Brazil Macular Degeneration Treatment Market Size, 2017-2028
        6.6.3 Argentina Macular Degeneration Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Macular Degeneration Treatment Revenue, 2017-2028
        6.7.2 Turkey Macular Degeneration Treatment Market Size, 2017-2028
        6.7.3 Israel Macular Degeneration Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Macular Degeneration Treatment Market Size, 2017-2028
        6.7.5 UAE Macular Degeneration Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Bausch Health Companies
        7.1.1 Bausch Health Companies Corporate Summary
        7.1.2 Bausch Health Companies Business Overview
        7.1.3 Bausch Health Companies Macular Degeneration Treatment Major Product Offerings
        7.1.4 Bausch Health Companies Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.1.5 Bausch Health Companies Key News
    7.2 Allergan
        7.2.1 Allergan Corporate Summary
        7.2.2 Allergan Business Overview
        7.2.3 Allergan Macular Degeneration Treatment Major Product Offerings
        7.2.4 Allergan Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.2.5 Allergan Key News
    7.3 Novartis
        7.3.1 Novartis Corporate Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Macular Degeneration Treatment Major Product Offerings
        7.3.4 Novartis Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.3.5 Novartis Key News
    7.4 Pfizer
        7.4.1 Pfizer Corporate Summary
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer Macular Degeneration Treatment Major Product Offerings
        7.4.4 Pfizer Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.4.5 Pfizer Key News
    7.5 Bayer
        7.5.1 Bayer Corporate Summary
        7.5.2 Bayer Business Overview
        7.5.3 Bayer Macular Degeneration Treatment Major Product Offerings
        7.5.4 Bayer Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.5.5 Bayer Key News
    7.6 Roche
        7.6.1 Roche Corporate Summary
        7.6.2 Roche Business Overview
        7.6.3 Roche Macular Degeneration Treatment Major Product Offerings
        7.6.4 Roche Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.6.5 Roche Key News
    7.7 Sanofi
        7.7.1 Sanofi Corporate Summary
        7.7.2 Sanofi Business Overview
        7.7.3 Sanofi Macular Degeneration Treatment Major Product Offerings
        7.7.4 Sanofi Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.7.5 Sanofi Key News
    7.8 Santen Pharmaceuticals
        7.8.1 Santen Pharmaceuticals Corporate Summary
        7.8.2 Santen Pharmaceuticals Business Overview
        7.8.3 Santen Pharmaceuticals Macular Degeneration Treatment Major Product Offerings
        7.8.4 Santen Pharmaceuticals Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.8.5 Santen Pharmaceuticals Key News
    7.9 Regeneron Pharmaceuticals
        7.9.1 Regeneron Pharmaceuticals Corporate Summary
        7.9.2 Regeneron Pharmaceuticals Business Overview
        7.9.3 Regeneron Pharmaceuticals Macular Degeneration Treatment Major Product Offerings
        7.9.4 Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.9.5 Regeneron Pharmaceuticals Key News
    7.10 Kanghong Pharma
        7.10.1 Kanghong Pharma Corporate Summary
        7.10.2 Kanghong Pharma Business Overview
        7.10.3 Kanghong Pharma Macular Degeneration Treatment Major Product Offerings
        7.10.4 Kanghong Pharma Macular Degeneration Treatment Revenue in Global Market (2017-2022)
        7.10.5 Kanghong Pharma Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Macular Degeneration Treatment Market Opportunities & Trends in Global Market
    Table 2. Macular Degeneration Treatment Market Drivers in Global Market
    Table 3. Macular Degeneration Treatment Market Restraints in Global Market
    Table 4. Key Players of Macular Degeneration Treatment in Global Market
    Table 5. Top Macular Degeneration Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Macular Degeneration Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Macular Degeneration Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Macular Degeneration Treatment Product Type
    Table 9. List of Global Tier 1 Macular Degeneration Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Macular Degeneration Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Macular Degeneration Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Macular Degeneration Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Macular Degeneration Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Macular Degeneration Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Macular Degeneration Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Macular Degeneration Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Macular Degeneration Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Macular Degeneration Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Macular Degeneration Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Macular Degeneration Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Bausch Health Companies Corporate Summary
    Table 31. Bausch Health Companies Macular Degeneration Treatment Product Offerings
    Table 32. Bausch Health Companies Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Allergan Corporate Summary
    Table 34. Allergan Macular Degeneration Treatment Product Offerings
    Table 35. Allergan Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Novartis Corporate Summary
    Table 37. Novartis Macular Degeneration Treatment Product Offerings
    Table 38. Novartis Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer Corporate Summary
    Table 40. Pfizer Macular Degeneration Treatment Product Offerings
    Table 41. Pfizer Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Bayer Corporate Summary
    Table 43. Bayer Macular Degeneration Treatment Product Offerings
    Table 44. Bayer Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Roche Corporate Summary
    Table 46. Roche Macular Degeneration Treatment Product Offerings
    Table 47. Roche Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Sanofi Corporate Summary
    Table 49. Sanofi Macular Degeneration Treatment Product Offerings
    Table 50. Sanofi Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Santen Pharmaceuticals Corporate Summary
    Table 52. Santen Pharmaceuticals Macular Degeneration Treatment Product Offerings
    Table 53. Santen Pharmaceuticals Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Regeneron Pharmaceuticals Corporate Summary
    Table 55. Regeneron Pharmaceuticals Macular Degeneration Treatment Product Offerings
    Table 56. Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Kanghong Pharma Corporate Summary
    Table 58. Kanghong Pharma Macular Degeneration Treatment Product Offerings
    Table 59. Kanghong Pharma Macular Degeneration Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Macular Degeneration Treatment Segment by Type in 2021
    Figure 2. Macular Degeneration Treatment Segment by Application in 2021
    Figure 3. Global Macular Degeneration Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Macular Degeneration Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Macular Degeneration Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Macular Degeneration Treatment Revenue in 2021
    Figure 8. By Type - Global Macular Degeneration Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Macular Degeneration Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Macular Degeneration Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Macular Degeneration Treatment Revenue Market Share, 2017-2028
    Figure 12. US Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Macular Degeneration Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Macular Degeneration Treatment Revenue Market Share, 2017-2028
    Figure 24. China Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Macular Degeneration Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Macular Degeneration Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Macular Degeneration Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Bausch Health Companies Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Allergan Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novartis Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Bayer Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Roche Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Sanofi Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Santen Pharmaceuticals Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Kanghong Pharma Macular Degeneration Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
66
Frequently Asked Questions
Macular Degeneration Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Macular Degeneration Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Macular Degeneration Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Raisins Market

A raisin is a dried grape. Raisins are produced in many regions of the world and may be eaten raw ... Read More